mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
BRD-K97651142 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.008 |
mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.009 |
mRNA |
BRD-K03911514 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.01 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.02 |
mRNA |
RO4929097 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.03 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.03 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.03 |